263769-26-2

Basic information

• Product Name: 4β-(4-chlorophenyl)-1-methyl-3α-n-propylpiperidine
• Synonyms: 4β-(4-chlorophenyl)-1-methyl-3α-n-propylpiperidine
• CAS NO: 263769-26-2
• Molecular Weight: 251.799
• Mol File: 263769-26-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4β-(4-chlorophenyl)-1-methyl-3α-n-propylpiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4β-(4-chlorophenyl)-1-methyl-3α-n-propylpiperidine(263769-26-2)
• EPA Substance Registry System: 4β-(4-chlorophenyl)-1-methyl-3α-n-propylpiperidine(263769-26-2)

Safety Data

• Hazardous Substances Data: 263769-26-2(Hazardous Substances Data)

Upstream product

• 63-75-2 arecoline 
• 214335-19-0 (3S,4S)-4-(4-chlorophenyl)-3-(hydroxymethyl)-1-methylpiperidine 
• 205805-13-6 (±)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3β-carboxylate 
• 214335-16-7 (-)-Methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3β-carboxylate 
• 873-77-8 (4-chlorphenyl)magnesium bromide 
• 263769-22-8 (+)-methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate 
• 263770-43-0 (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carbaldehyde 
• 263769-24-0 (+)-4β-(4-Chlorophenyl)-3α-(hydroxymethyl)-1-methylpiperidine 
• 263770-46-3 (3R,4S)-4-(4-Chloro-phenyl)-1-methyl-3-((E)-propenyl)-piperidine 

Downstream Products

• 263769-36-4 (+)-4β-(4-Chlorophenyl)-3α-n-propylpiperidine 

Relevant articles and documents

Synthesis, molecular modeling, and biological studies of novel piperidine-based analogues of cocaine: Evidence of unfavorable interactions proximal to the 3α-position of the piperidine ring

A qualitative model for the binding pocket proximal to the 3α-substituent of the piperidine-based monoamine transporter ligands was proposed and tested. Based on this model, a new series of druglike 3α-modified piperidine-based analogues of cocaine were d

Analogs of cocaine

The invention provides a compound of formula (I): STR1wherein R 1, R 2, R 3, and Y have any of the meanings defined in the specification; as well a pharmaceutical composition comprising a compound of formula I; intermediates and methods useful for preparing a compound of formula I; and therapeutic methods for treating drug addiction, Parkinson''s disease or depression comprising administering a compound of formula I, to a mammal in need of such treatment.